2-Week Study In People With Nonalcoholic Fatty Liver Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
2-week study in people with nonalcoholic fatty liver disease. Study drug at 1 of 2 doses, or placebo, will be given for 14 days. Blood samples, heart monitoring, vital signs, and imaging procedures will be performed.
Epistemonikos ID: 7220d6ea9bf4abb2b17d30beab2aca7eb74e6c8d
First added on: May 21, 2024